GlassScriptPhysician profile
Katherine A Horner
NPI 1285789420
$3,672.45
in general payments reported to CMS, 2019-2025
43 companies · $1,075 in 2025
The $1,075 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $776 · 2022: $635 · 2023: $503 · 2024: $684 · 2025: $1,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,261.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,021.08 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $226.44 | 2021-2025 | Airsupra, Xigduo |
| Amgen INC. | $210.52 | 2025 | Repatha, Evenity, Otezla |
| Sanofi-Aventis U.S. LLC | $193.76 | 2021-2024 | |
| Novo Nordisk INC | $185.51 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Antares Pharma, INC. | $179.15 | 2021-2025 | Xyosted |
| Otsuka America Pharmaceutical, INC. | $142.20 | 2022-2025 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $139.50 | 2025 | Evkeeza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.97 | 2023-2025 | Xifaxan |
| Pfizer INC. | $116.55 | 2021-2025 | |
| Mylan Specialty L.P. | $96.17 | 2023-2024 | Yupelri |
| Upsher-Smith Laboratories LLC | $69.14 | 2021 | |
| Lilly USA, LLC | $65.88 | 2021 | |
| Grifols USA, LLC | $61.85 | 2022-2023 | Prolastin-C Liquid |
| Boston Scientific Corporation | $52.56 | 2022-2024 | Watchman Flx |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Horner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.